Over the past two decades, Rebecca Lambert has extensively investigated the underlying drivers of deadly, complex, chronic diseases with a focus on angiogenesis and immune surveillance. Ms. Lambert is the inventor of patent-pending applications which address measuring and manipulating imbalanced angiogenic regulators for both the diagnosis and treatment of disease. This work began in 2001 when her sister, diagnosed with Stage IV leiomyosarcoma (LMS), was given less than a year to live. (LMS is generally not responsive to treatment). Ms. Lambert, whose efforts were guided by leading cancer researchers throughout the country, became determined to understand what was driving her sister’s disease. Ms. Lambert focused on extensive research studies citing angiogenesis’ role in permitting Stage I, avascular (without blood vessel connection) and benign cancers to move to Stage II and potentially fatal disease.
Angiogenesis research was pioneered in 1970 by Harvard’s Dr. Judah Folkman, who generously supported Ms Lambert’s efforts. These efforts focused on assembling a combination of research proven components for her sister which permitted Ms. Lambert’s sister to live nine years- as opposed to just one- with eight of these nine years having full quality of life.
Ms. Lambert founded ASSIST Medical Research foundation to fund translational medical research for therapies and diagnostics to treat complex chronic disease, particularly those driven by angiogenesis.
Career Highlights
Rebecca Lambert has over thirty-five (35) years of experience in designing and executing strategies for complex issues confronting business, government, political, healthcare, and financial entities.
As VP of Shaker Investments, Ms. Lambert led its efforts to raise $1 billion of funds under management. Her Federal Government experience, includes positions as:
Associate Deputy Secretary of the U.S. Department of Commerce, Deputy Assistant Secretary of the U.S. Department of Energy, and Chief of Staff for U.S. Senator Malcolm Wallop (WY) and US Sen. Ted Stevens in his capacity as Chairman of the Republican Senatorial Committee. In the broadcasting industry, she created the largest multi-channel television network serving U.S. hospitals. Previously, she acquired rural FM radio properties to upgrade each to become top 100 market station (which were subsequently acquired by major broadcasting companies).
Ms. Lambert is currently Founder and Executive Chairman of NED Biosystems, Inc. (www.nedbiosystems.com). NED Biosystems is a clinical-stage company developing combination cancer treatments. Its mission is to develop therapies that improve outcomes and maintain patients’ high quality of life.
Ms. Lambert has a B.A. in political science from Simmons College, attended Williams College and the Harvard Business School’s Advanced Management Program. When living in New York City, Ms Lambert was President of Board of Bellevue Hospital’s Association.